Logo image of ABO.BR

ABO GROUP ENVIRONMENT (ABO.BR) Stock Fundamental Analysis

Europe - EBR:ABO - BE0974278104 - Common Stock

6 EUR
0 (0%)
Last: 9/15/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, ABO scores 4 out of 10 in our fundamental rating. ABO was compared to 40 industry peers in the Commercial Services & Supplies industry. ABO has only an average score on both its financial health and profitability. ABO is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year ABO was profitable.
In the past year ABO had a positive cash flow from operations.
Each year in the past 5 years ABO has been profitable.
In the past 5 years ABO always reported a positive cash flow from operatings.
ABO.BR Yearly Net Income VS EBIT VS OCF VS FCFABO.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

1.2 Ratios

With a Return On Assets value of 1.93%, ABO perfoms like the industry average, outperforming 55.00% of the companies in the same industry.
ABO has a Return On Equity (7.34%) which is in line with its industry peers.
Looking at the Return On Invested Capital, with a value of 6.90%, ABO is in the better half of the industry, outperforming 72.50% of the companies in the same industry.
ABO had an Average Return On Invested Capital over the past 3 years of 6.75%. This is in line with the industry average of 7.18%.
The last Return On Invested Capital (6.90%) for ABO is above the 3 year average (6.75%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.93%
ROE 7.34%
ROIC 6.9%
ROA(3y)2.67%
ROA(5y)2.95%
ROE(3y)9.24%
ROE(5y)10%
ROIC(3y)6.75%
ROIC(5y)6.66%
ABO.BR Yearly ROA, ROE, ROICABO.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

ABO has a Profit Margin of 1.98%. This is comparable to the rest of the industry: ABO outperforms 57.50% of its industry peers.
In the last couple of years the Profit Margin of ABO has declined.
Looking at the Operating Margin, with a value of 5.11%, ABO is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
ABO's Operating Margin has declined in the last couple of years.
ABO's Gross Margin of 82.71% is amongst the best of the industry. ABO outperforms 82.50% of its industry peers.
In the last couple of years the Gross Margin of ABO has declined.
Industry RankSector Rank
OM 5.11%
PM (TTM) 1.98%
GM 82.71%
OM growth 3Y6%
OM growth 5Y-3.01%
PM growth 3Y-14.39%
PM growth 5Y-11.63%
GM growth 3Y-2.08%
GM growth 5Y-1.79%
ABO.BR Yearly Profit, Operating, Gross MarginsABO.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ABO is creating some value.
Compared to 1 year ago, ABO has about the same amount of shares outstanding.
The number of shares outstanding for ABO remains at a similar level compared to 5 years ago.
ABO has a worse debt/assets ratio than last year.
ABO.BR Yearly Shares OutstandingABO.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ABO.BR Yearly Total Debt VS Total AssetsABO.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

ABO has an Altman-Z score of 2.04. This is not the best score and indicates that ABO is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.04, ABO is doing good in the industry, outperforming 67.50% of the companies in the same industry.
ABO has a debt to FCF ratio of 12.48. This is a negative value and a sign of low solvency as ABO would need 12.48 years to pay back of all of its debts.
ABO has a Debt to FCF ratio (12.48) which is in line with its industry peers.
A Debt/Equity ratio of 0.63 indicates that ABO is somewhat dependend on debt financing.
ABO has a Debt to Equity ratio (0.63) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 12.48
Altman-Z 2.04
ROIC/WACC1.13
WACC6.1%
ABO.BR Yearly LT Debt VS Equity VS FCFABO.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.3 Liquidity

ABO has a Current Ratio of 1.09. This is a normal value and indicates that ABO is financially healthy and should not expect problems in meeting its short term obligations.
ABO's Current ratio of 1.09 is on the low side compared to the rest of the industry. ABO is outperformed by 62.50% of its industry peers.
A Quick Ratio of 1.06 indicates that ABO should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.06, ABO perfoms like the industry average, outperforming 57.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.06
ABO.BR Yearly Current Assets VS Current LiabilitesABO.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

4

3. Growth

3.1 Past

ABO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.90%.
Measured over the past 5 years, ABO shows a small growth in Earnings Per Share. The EPS has been growing by 1.48% on average per year.
ABO shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.63%.
Measured over the past years, ABO shows a quite strong growth in Revenue. The Revenue has been growing by 14.83% on average per year.
EPS 1Y (TTM)-24.9%
EPS 3Y-1.79%
EPS 5Y1.48%
EPS Q2Q%-22.64%
Revenue 1Y (TTM)14.63%
Revenue growth 3Y14.71%
Revenue growth 5Y14.83%
Sales Q2Q%14.96%

3.2 Future

Based on estimates for the next years, ABO will show a decrease in Earnings Per Share. The EPS will decrease by -0.46% on average per year.
Based on estimates for the next years, ABO will show a quite strong growth in Revenue. The Revenue will grow by 14.99% on average per year.
EPS Next YN/A
EPS Next 2Y5.71%
EPS Next 3Y-0.46%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2Y23.53%
Revenue Next 3Y14.99%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ABO.BR Yearly Revenue VS EstimatesABO.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 2027 20M 40M 60M 80M 100M
ABO.BR Yearly EPS VS EstimatesABO.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2026 2027 0.1 0.2 0.3 0.4 0.5

2

4. Valuation

4.1 Price/Earnings Ratio

ABO is valuated quite expensively with a Price/Earnings ratio of 33.33.
ABO's Price/Earnings ratio is in line with the industry average.
ABO is valuated rather expensively when we compare the Price/Earnings ratio to 27.27, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 33.33
Fwd PE N/A
ABO.BR Price Earnings VS Forward Price EarningsABO.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ABO indicates a somewhat cheap valuation: ABO is cheaper than 67.50% of the companies listed in the same industry.
ABO's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 20.76
EV/EBITDA 6.96
ABO.BR Per share dataABO.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The decent profitability rating of ABO may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)22.55
EPS Next 2Y5.71%
EPS Next 3Y-0.46%

2

5. Dividend

5.1 Amount

ABO has a Yearly Dividend Yield of 1.55%.
ABO's Dividend Yield is comparable with the industry average which is at 4.32.
ABO's Dividend Yield is slightly below the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.55%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y5.71%
EPS Next 3Y-0.46%
ABO.BR Yearly Income VS Free CF VS DividendABO.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

ABO GROUP ENVIRONMENT

EBR:ABO (9/15/2025, 7:00:00 PM)

6

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.28%
Inst Owner ChangeN/A
Ins Owners85.24%
Ins Owner ChangeN/A
Market Cap63.42M
Analysts84
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.55%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 33.33
Fwd PE N/A
P/S 0.66
P/FCF 20.76
P/OCF 8.18
P/B 2.45
P/tB 4.2
EV/EBITDA 6.96
EPS(TTM)0.18
EY3%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.29
FCFY4.82%
OCF(TTM)0.73
OCFY12.22%
SpS9.07
BVpS2.44
TBVpS1.43
PEG (NY)N/A
PEG (5Y)22.55
Profitability
Industry RankSector Rank
ROA 1.93%
ROE 7.34%
ROCE 9.97%
ROIC 6.9%
ROICexc 9.5%
ROICexgc 13.6%
OM 5.11%
PM (TTM) 1.98%
GM 82.71%
FCFM 3.19%
ROA(3y)2.67%
ROA(5y)2.95%
ROE(3y)9.24%
ROE(5y)10%
ROIC(3y)6.75%
ROIC(5y)6.66%
ROICexc(3y)10.47%
ROICexc(5y)11.44%
ROICexgc(3y)13.66%
ROICexgc(5y)14.41%
ROCE(3y)9.75%
ROCE(5y)9.61%
ROICexcg growth 3Y3.29%
ROICexcg growth 5Y5.77%
ROICexc growth 3Y-2.3%
ROICexc growth 5Y0.98%
OM growth 3Y6%
OM growth 5Y-3.01%
PM growth 3Y-14.39%
PM growth 5Y-11.63%
GM growth 3Y-2.08%
GM growth 5Y-1.79%
F-Score6
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 12.48
Debt/EBITDA 1.29
Cap/Depr 60.56%
Cap/Sales 4.9%
Interest Coverage 3.48
Cash Conversion 61.27%
Profit Quality 161.04%
Current Ratio 1.09
Quick Ratio 1.06
Altman-Z 2.04
F-Score6
WACC6.1%
ROIC/WACC1.13
Cap/Depr(3y)61.35%
Cap/Depr(5y)64.84%
Cap/Sales(3y)4.92%
Cap/Sales(5y)5.25%
Profit Quality(3y)155.26%
Profit Quality(5y)177.18%
High Growth Momentum
Growth
EPS 1Y (TTM)-24.9%
EPS 3Y-1.79%
EPS 5Y1.48%
EPS Q2Q%-22.64%
EPS Next YN/A
EPS Next 2Y5.71%
EPS Next 3Y-0.46%
EPS Next 5YN/A
Revenue 1Y (TTM)14.63%
Revenue growth 3Y14.71%
Revenue growth 5Y14.83%
Sales Q2Q%14.96%
Revenue Next YearN/A
Revenue Next 2Y23.53%
Revenue Next 3Y14.99%
Revenue Next 5YN/A
EBIT growth 1Y4.44%
EBIT growth 3Y21.59%
EBIT growth 5Y11.37%
EBIT Next YearN/A
EBIT Next 3Y34.11%
EBIT Next 5YN/A
FCF growth 1Y-19.09%
FCF growth 3Y9.03%
FCF growth 5Y-6.88%
OCF growth 1Y0.65%
OCF growth 3Y4.61%
OCF growth 5Y4.02%